Loading organizations...
Tecan Group specializes in developing and distributing automated workflow solutions and advanced laboratory automation products for the life sciences and clinical diagnostics sectors. The company's portfolio includes sophisticated liquid handling systems, such as its Fluent® and Veya® platforms, along with a range of other automation instruments, smart consumables, and supporting services. These technologies are designed to enhance the precision, efficiency, and scalability of measurement and analysis within laboratory environments.
The company was founded in 1980 by four engineers in Hombrechtikon, Switzerland. Their initial vision was to advance the capabilities of measurement, analysis, and laboratory automation. This foundational insight addressed the burgeoning need for streamlined and accurate processes within scientific research and medical diagnostics, recognizing the potential for automation to accelerate discovery and improve diagnostic outcomes.
Tecan's solutions are employed by diverse laboratories globally, including academic research institutions, pharmaceutical companies, and clinical diagnostic facilities. The company's enduring mission is to improve people's lives and health by empowering its customers to scale healthcare innovation worldwide. Tecan remains committed to providing indispensable tools that contribute to progress in biological research and patient care.
Key people at Tecan Group.
Tecan Group was founded in 1980 by Heinz Abplanalp (Founder) and Gallus Blater (Founder) and Heini Maurer (Founder).
Tecan Group was founded in 1980 by Heinz Abplanalp (Founder) and Gallus Blater (Founder) and Heini Maurer (Founder).
Tecan Group has 1 tracked investment across 1 company. The latest tracked deal is $4.9M Series B in Labforward in January 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 11, 2021 | Labforward | $4.9M Series B | Tecan Group | — |
Key people at Tecan Group.